title: Response criteria for malignant lymphoma.
abstract: In the last 35 years, many attempts have been made to define criteria for the assessment of treatment response in malignant lymphoma. These systems, with respect to both morphological and molecular imaging, aim to standardize scan results, in order to simplify the interpretation of findings, facilitate multicentric research trials, and compare published data. Unfortunately, there is no consensus among the main international hematological associations on which criteria are the most appropriate. This detailed and comprehensive description of all classifications intends to focus attention on this topic.
authors.affiliation: aNuclear Medicine and PET Unit bOncoematology Unit cPathology Unit dRadiation therapy Unit, Santa Maria della Misericordia Hospital, Rovigo, Italy.
authors.forename: Anna M
authors.initials: AM
authors.lastname: Maffione
authors.forename: Rossella
authors.initials: R
authors.lastname: Paolini
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Rodella
authors.forename: Cristina
authors.initials: C
authors.lastname: Ambrosio
authors.forename: Lucia
authors.initials: L
authors.lastname: Rampin
authors.forename: Laura C
authors.initials: LC
authors.lastname: Lisato
authors.forename: Maria
authors.initials: M
authors.lastname: Ballotta
authors.forename: Giovanni
authors.initials: G
authors.lastname: Pavanato
authors.forename: Domenico
authors.initials: D
authors.lastname: Rubello
mesh_terms: D003952:Diagnostic Imaging / Q000592:standards*; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000628:therapy*; D049268:Positron-Emission Tomography; D012015:Reference Standards; D016896:Treatment Outcome